Related Experiment Video
Updated: May 12, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
Sensitivity in statistical evaluation of biomarkers
Wen Li1, Yongming Qu, Pandurang M Kulkarni
1Singapore Clinical Research Institute, 31 Biopolis Way, Nanos 02-01, Singapore 138669. cherrycolee@hotmail.com
Accurate biomarker quantification is crucial for predicting patient outcomes and guiding treatment. This study demonstrates that using the change in biomarker levels, or the adjusted actual value, is more appropriate than using the actual value alone for evaluating marker effectiveness.
Area of Science:
- Biostatistics
- Clinical Research
- Medical Informatics
Background:
- Biomarkers are essential in clinical research for understanding disease progression and informing treatment decisions.
- Accurate quantification of biomarkers is critical for predicting individual patient outcomes.
- Statistical validation methods for biomarkers exist but their application to real-world data requires further study.
Purpose of the Study:
- To investigate the most appropriate method for quantifying biomarkers in clinical practice.
- To determine whether the change in a biomarker or its actual assessed value is superior for predicting clinical outcomes.
- To provide evidence-based recommendations for biomarker evaluation.
Main Methods:
- Theoretical analysis of biomarker quantification methods.
- Computer simulations to assess the performance of different approaches.
- Application of methods to a real clinical dataset for evaluation.
Main Results:
- The study found that using the actual biomarker value alone is less appropriate for predicting clinical outcomes.
- Quantifying biomarkers by their change from baseline or by using the actual value adjusted for baseline is theoretically and practically superior.
- Simulation and real-data examples supported the efficacy of using change or adjusted actual values.
Conclusions:
- The evaluation of biomarkers for predicting clinical outcomes should prioritize the change in marker levels or the baseline-adjusted actual value.
- Current practices often rely on less optimal methods, highlighting a need for methodological refinement in clinical research.
- Adopting recommended quantification strategies can improve the precision of biomarker-based treatment decisions.
Related Concept Videos
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Data: Statistical Interpretation
Receiver Operating Characteristic Plot
Accuracy and Errors in Hypothesis Testing
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5% chance...
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance, comparing...

